Hu_2015_PLoS.One_10_e0139862

Reference

Title : Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial - Hu_2015_PLoS.One_10_e0139862
Author(s) : Hu C , Tompson D , Magee M , Chen Q , Liu YM , Zhu W , Zhao H , Gross AS , Liu Y
Ref : PLoS ONE , 10 :e0139862 , 2015
Abstract : Hu_2015_PLoS.One_10_e0139862
ESTHER : Hu_2015_PLoS.One_10_e0139862
PubMedSearch : Hu_2015_PLoS.One_10_e0139862
PubMedID: 26465780

Related information

Citations formats

Hu C, Tompson D, Magee M, Chen Q, Liu YM, Zhu W, Zhao H, Gross AS, Liu Y (2015)
Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial
PLoS ONE 10 :e0139862

Hu C, Tompson D, Magee M, Chen Q, Liu YM, Zhu W, Zhao H, Gross AS, Liu Y (2015)
PLoS ONE 10 :e0139862